Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125413472 | 12541347 | 2 | F | 201604 | 20160807 | 20160708 | 20160812 | EXP | US-JNJFOC-20160327582 | JANSSEN | 51.97 | YR | A | M | Y | 138.80000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125413472 | 12541347 | 1 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | INITIATED IN MAR-2016 OR APR-2016 | Y | N | UNKNOWN | 103772 | LYOPHILIZED POWDER | ||||||
| 125413472 | 12541347 | 2 | C | LIOTHYRONINE | LIOTHYRONINE | 1 | Unknown | 0 | 5 | UG | UNSPECIFIED | ||||||||
| 125413472 | 12541347 | 3 | C | LIOTHYRONINE | LIOTHYRONINE | 1 | Unknown | 0 | 5 | UG | UNSPECIFIED | ||||||||
| 125413472 | 12541347 | 4 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125413472 | 12541347 | 5 | C | COLCRYS | COLCHICINE | 1 | Unknown | 0 | .6 | MG | UNSPECIFIED | ||||||||
| 125413472 | 12541347 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 | 1 | MG | UNSPECIFIED | ||||||||
| 125413472 | 12541347 | 7 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 2.5 | MG | TABLETS | ||||||||
| 125413472 | 12541347 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | 300 | MG | UNSPECIFIED | ||||||||
| 125413472 | 12541347 | 9 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | Unknown | 0 | 25 | MG | UNSPECIFIED | ||||||||
| 125413472 | 12541347 | 10 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | 75 | MG | UNSPECIFIED | ||||||||
| 125413472 | 12541347 | 11 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | 0 | 160 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125413472 | 12541347 | 1 | Psoriatic arthropathy |
| 125413472 | 12541347 | 2 | Tendon disorder |
| 125413472 | 12541347 | 3 | Muscle disorder |
| 125413472 | 12541347 | 4 | Muscle relaxant therapy |
| 125413472 | 12541347 | 5 | Prophylaxis |
| 125413472 | 12541347 | 6 | Prophylaxis |
| 125413472 | 12541347 | 8 | Blood sodium increased |
| 125413472 | 12541347 | 10 | Stent placement |
| 125413472 | 12541347 | 11 | Blood cholesterol |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125413472 | 12541347 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125413472 | 12541347 | Back pain | |
| 125413472 | 12541347 | Dyspnoea | |
| 125413472 | 12541347 | Hypersensitivity | |
| 125413472 | 12541347 | Infusion related reaction | |
| 125413472 | 12541347 | Loss of consciousness | |
| 125413472 | 12541347 | Seizure | |
| 125413472 | 12541347 | Skin discolouration | |
| 125413472 | 12541347 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125413472 | 12541347 | 1 | 2016 | 201604 | 0 |